Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miss TOP MA: Two-day versus one-day mifepristone–misoprostol interval for late second trimester medical abortion
PACTR202412756696775Phase 4Not yet recruiting
- Sponsor
- St. Paul Institute for Reproductive Health and Rights
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mifepristone and misoprostol in abortion (2 arms), sponsored by St. Paul Institute for Reproductive Health and Rights. Primary endpoint: Mean induction-to-expulsion interval. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
mifepristonemisoprostol
03
Conditions
abortion
Beyond the preview
Go deeper on PACTR202412756696775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412756696775.